Literature DB >> 7191707

Chemistry, physiology, and therapeutic applications of calcitonin.

I MacIntyre, I M Evans, H H Hobitz, G F Joplin, J C Stevenson.   

Abstract

The chemistry and physiology of calcitonin are reviewed with particular emphasis on the evolution of the hormone and its modern role in humans. It seems likely that the relative deficiency of calcitonin in women may be important in postmenopausal bone loss. A major therapeutic application of calcitonin is in the treatment of Paget's disease of bone, and current recommendations for therapy are presented.

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7191707     DOI： 10.1002/art.1780231011

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


  18 in total

1.  A double-blind, multicentre, placebo-controlled study of tiludronate in Paget's disease of bone.

Authors:  W D Fraser; T C Stamp; R A Creek; J P Sawyer; C Picot
Journal:  Postgrad Med J       Date:  1997-08       Impact factor: 2.401

2.  Widespread tremor after injection of sodium calcitonin.

Authors:  J I Conget; J Vendrell; I Halperin; E Esmatjes
Journal:  BMJ       Date:  1989-01-21

3.  Calcitonin has direct effects on 3[H]-thymidine incorporation and alkaline phosphatase activity in human osteoblast-line cells.

Authors:  J R Farley; J E Wergedal; S L Hall; S Herring; N M Tarbaux
Journal:  Calcif Tissue Int       Date:  1991-05       Impact factor: 4.333

4.  Intranasal calcitonin and plasma calcium concentrations.

Authors:  J C Stevenson
Journal:  Br Med J (Clin Res Ed)       Date:  1985-07-06

5.  Paget's disease of bone: early and late responses to three different modes of treatment with aminohydroxypropylidene bisphosphonate (APD).

Authors:  H I Harinck; S E Papapoulos; H J Blanksma; A J Moolenaar; P Vermeij; O L Bijvoet
Journal:  Br Med J (Clin Res Ed)       Date:  1987-11-21

6.  Calcitonin acutely increases tyrosyl-phosphorylation of proteins in human osteosarcoma (SaOS-2) cells.

Authors:  A Thomas; S L Hall; V Nicolas; K H Lau; J R Farley
Journal:  Calcif Tissue Int       Date:  1995-04       Impact factor: 4.333

7.  The construction and partial characterization of plasmids containing complementary DNA sequences to human calcitonin precursor polyprotein.

Authors:  J Allison; L Hall; I MacIntyre; R K Craig
Journal:  Biochem J       Date:  1981-12-01       Impact factor: 3.857

Review 8.  Paget's disease of bone.

Authors:  D J Hosking
Journal:  Br Med J (Clin Res Ed)       Date:  1981-09-12

Review 9.  Drugs used in the treatment of metabolic bone disease. Clinical pharmacology and therapeutic use.

Authors:  S Patel; A R Lyons; D J Hosking
Journal:  Drugs       Date:  1993-10       Impact factor: 9.546

10.  Response of Paget's disease to human calcitonin in patients resistant to porcine calcitonin.

Authors:  V Lo Cascio; S Adami; G Galvanini; R Lazzaretto; M Ferrari; D Tartarotti; L A Scuro
Journal:  J Endocrinol Invest       Date:  1984-04       Impact factor: 4.256
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.